Literature DB >> 23959744

Religious perspectives on the use of psychopharmaceuticals as an enhancement technology.

Scott J Fitzpatrick, Christopher F C Jordens, Ian H Kerridge, Damien Keown, James J Walter, Paul Nelson, Mohamad Abdalla, Lisa Soleymani Lehmann, Deepak Sarma.   

Abstract

The use of psychopharmaceuticals as an enhancement technology has been the focus of attention in the bioethics literature. However, there has been little examination of the challenges that this practice creates for religious traditions that place importance on questions of being, authenticity, and identity. We asked expert commentators from six major world religions to consider the issues raised by psychopharmaceuticals as an enhancement technology. These commentaries reveal that in assessing the appropriate place of medical therapies, religious traditions, like secular perspectives, rely upon ideas about health and disease and about normal human behavior. But unlike secular perspectives, faith traditions explicitly concern themselves with ways in which medicine should or should not be used to live a "good life".

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23959744     DOI: 10.1007/s10943-013-9761-7

Source DB:  PubMed          Journal:  J Relig Health        ISSN: 0022-4197


  11 in total

1.  The ethics of genetic manipulation.

Authors: 
Journal:  Origins       Date:  1983-11-17

2.  Lost in translation: religious arguments made secular.

Authors:  Carson Strong
Journal:  Am J Bioeth       Date:  2005       Impact factor: 11.229

3.  Cosmetic psychopharmacology and the President's Council on Bioethics.

Authors:  Michael A Cerullo
Journal:  Perspect Biol Med       Date:  2006       Impact factor: 1.416

Review 4.  Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review.

Authors:  S H Kollins; E K MacDonald; C R Rush
Journal:  Pharmacol Biochem Behav       Date:  2001-03       Impact factor: 3.533

5.  Towards responsible use of cognitive-enhancing drugs by the healthy.

Authors:  Henry Greely; Barbara Sahakian; John Harris; Ronald C Kessler; Michael Gazzaniga; Philip Campbell; Martha J Farah
Journal:  Nature       Date:  2008-12-11       Impact factor: 49.962

6.  Enhancements, easy shortcuts, and the richness of human activities.

Authors:  Maartje Schermer
Journal:  Bioethics       Date:  2007-04-25       Impact factor: 1.898

7.  Is better always good? The Enhancement Project.

Authors:  E Parens
Journal:  Hastings Cent Rep       Date:  1998 Jan-Feb       Impact factor: 2.683

8.  Recent trends in the use of antidepressant drugs in Australia, 1990-1998.

Authors:  P McManus; A Mant; P B Mitchell; W S Montgomery; J Marley; M E Auland
Journal:  Med J Aust       Date:  2000-11-06       Impact factor: 7.738

9.  A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study.

Authors:  J A Caldwell; J L Caldwell; N K Smythe; K K Hall
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

10.  Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Authors:  David Michelson; Lenard Adler; Thomas Spencer; Frederick W Reimherr; Scott A West; Albert J Allen; Douglas Kelsey; Joachim Wernicke; Anthony Dietrich; Denái Milton
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.